The Accounts · daily brief
13 May 2026
Cost cuts, accounting quirks and a margin squeeze
The takeaways
- A hefty prior-year pension charge flatters the profit growth at A1 Pharmaceuticals
- Watch the calendar at 4 Ways Healthcare; a nine-month prior period skews comparisons
- Flat sales and a rising headcount proved a heavy drag on Red Band's operating margins
A1 Pharmaceuticals Holdings Limited [1]
Pension swing
| Line | FY25 | FY24 |
|---|---|---|
| Turnover | £60m▲ +7% | £56m |
| Operating profit | £3.2m▲ +59% | £2.0m |
| Profit before tax | £3.4m▲ +52% | £2.3m |
| Net profit | £2.7m▲ +67% | £1.6m |
| Avg. headcount | 54▲ +4% | 52 |
| Staff cost | £2.3m▼ −17% | £2.8m |
Top-line growth is present, but the real heavy lifting for this group’s 60% operating profit jump happened on the cost side. Administrative expenses shrank by 8.7%, largely because a hefty £726k pension charge from the prior year was not repeated. Stripping out the noise, underlying margins are indeed healthier, though the £358k related-party rent cheque to the landlords remains a notable feature.
4 Ways Healthcare Limited [2]
Distorted baseline
| Line | FY24 | FY23 |
|---|---|---|
| Turnover | £47m▲ +37% | £34m |
| Operating profit | £9.5m▲ +41% | £6.8m |
| Profit before tax | £9.7m▲ +40% | £6.9m |
| Net profit | £9.0m▲ +53% | £5.9m |
| Avg. headcount | 160▼ −4% | 166 |
| Staff cost | £2.3m▲ +31% | £1.7m |
| Director pay | £457k▲ +28% | £358k |
The headline growth figures require a careful calendar check; the prior accounting period was only nine months long, mechanically elevating the year-on-year trajectory. Annualise the historic turnover and the top line is actually rather flat, though achieving it with a slightly reduced headcount represents a genuine productivity gain. The going-concern note is worth a glance, modelling a stated 'no monthly revenue growth' scenario from mid-2025 under which the board projects sufficient headroom.
"Red Band" Chemical Company, Limited [3]
Squeezed into red
| Line | FY24 | FY23 |
|---|---|---|
| Turnover | £43m▼ −0% | £44m |
| Operating profit | −£156k▼ −151% | £306k |
| Profit before tax | −£455k▲ +66% | −£1.3m |
| Net profit | −£420k▲ +66% | −£1.2m |
| Avg. headcount | 362▲ +10% | 329 |
| Staff cost | £11m▲ +9% | £9.9m |
A classic, structural margin squeeze. Revenues flatlined, but the board still added over thirty heads to the payroll, pushing total staff costs up by nearly a million pounds. That resulting climb in administrative expenses was more than enough to drag an already fragile operating margin firmly into the red. The expanding staff cost base simply outpaced static revenues during the period under review.
Three different ways to manage a payroll, only one of which expands the margin.
Sources
- A1 Pharmaceuticals Holdings Limited — Companies House filing history
- 4 Ways Healthcare Limited — Companies House filing history
- "Red Band" Chemical Company, Limited — Companies House filing history